Total medical devices industry cross border M&A deals worth $592.6m were announced globally in January 2022, led by ConvaTec Group’s $450m acquisition of Triad Life Sciences, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 57.4% over the previous month of $1.39bn and a drop of 66.3% when compared with the last 12-month average, which stood at $1.76bn.
Comparing cross border M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $585m. At the country level, the US topped the list in terms of deal value at $585m.
In terms of volumes, Europe emerged as the top region for medical devices industry cross border M&A deals globally, followed by North America and then South and Central America.
The top country in terms of cross border M&A deals activity in January 2022 was the US with five deals, followed by the UK with four and Germany with two.
In 2022, as of January, medical devices cross border M&A deals worth $592.62m were announced globally, marking an increase of 67.6% year on year.
medical devices industry cross border M&A deals in January 2022: Top deals
The top three cross border M&A deals accounted for 99.9% of the overall value during January 2022.
The combined value of the top three medical devices cross border M&A deals stood at $592.12m, against the overall value of $592.6m recorded for the month.
The top three medical devices industry cross border M&A deals of January 2022 tracked by GlobalData were:
1) ConvaTec Group $450m acquisition deal with Triad Life Sciences
2) The $135m acquisition of Engage Surgical by Smith & Nephew International
3) Prolight Diagnostics $7.12m acquisition deal with Psyros Diagnostics.